aluates Reports

$ 0.0

Automative

Global Pharmaceutics and Novel Drug Delivery Systems Market Research Report 2024

Published Date: May 2024

Report Code: QYRE-Auto-13W9949

Global Pharmaceutics and Novel Drug Delivery Systems Market Insights Forecast to 2028

BUY CHAPTERS

Global Pharmaceutics and Novel Drug Delivery Systems Market Research Report 2024

Code: QYRE-Auto-13W9949

Report

May 2024

Pages:100

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Pharmaceutics and Novel Drug Delivery Systems Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Pharmaceutics and Novel Drug Delivery Systems Market

Novel drug delivery is a method of delivering medication to a patient in a manner that increases the concentration of the medication in some parts of the body relative to others.

The global Pharmaceutics and Novel Drug Delivery Systems market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Pharmaceutics and Novel Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutics and Novel Drug Delivery Systems.

Report Scope

The Pharmaceutics and Novel Drug Delivery Systems market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutics and Novel Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pharmaceutics and Novel Drug Delivery Systems companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Pharmaceutics and Novel Drug Delivery Systems Market Report

Report Metric	Details
Report Name	Pharmaceutics and Novel Drug Delivery Systems Market
CAGR	5%
Segment by Type	Liposomes PEGylated Proteins & Polypeptides Polymer Nanoparticle Protein–drug Conjugates Other
Segment by Application	Hospitals & Clinic Cancer Treatment Centers Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Amgen, Teva, Roche, UCB (Union Chimique Belge), Celgene, Merck, Gilead Sciences, Sanofi, Pfizer, Takeda, Bausch&Lomb, Samyang Biopharmaceuticals, Johnson & Johnson, TOLMAR, Astellas, AMAG Pharmaceuticals, AbbVie, Dr Reddy, AstraZeneca, Aspen, Acrotech Biopharma, TWi Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutics and Novel Drug Delivery Systems companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pharmaceutics and Novel Drug Delivery Systems Market report?

Ans: The main players in the Pharmaceutics and Novel Drug Delivery Systems Market are Amgen, Teva, Roche, UCB (Union Chimique Belge), Celgene, Merck, Gilead Sciences, Sanofi, Pfizer, Takeda, Bausch&Lomb, Samyang Biopharmaceuticals, Johnson & Johnson, TOLMAR, Astellas, AMAG Pharmaceuticals, AbbVie, Dr Reddy, AstraZeneca, Aspen, Acrotech Biopharma, TWi Pharmaceuticals

What are the Application segmentation covered in the Pharmaceutics and Novel Drug Delivery Systems Market report?

Ans: The Applications covered in the Pharmaceutics and Novel Drug Delivery Systems Market report are Hospitals & Clinic, Cancer Treatment Centers, Others

What are the Type segmentation covered in the Pharmaceutics and Novel Drug Delivery Systems Market report?

Ans: The Types covered in the Pharmaceutics and Novel Drug Delivery Systems Market report are Liposomes, PEGylated Proteins & Polypeptides, Polymer Nanoparticle, Protein–drug Conjugates, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Liposomes

1.2.3 PEGylated Proteins & Polypeptides

1.2.4 Polymer Nanoparticle

1.2.5 Protein–drug Conjugates

1.2.6 Other

1.3 Market by Application

1.3.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals & Clinic

1.3.3 Cancer Treatment Centers

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Perspective (2019-2030)

2.2 Pharmaceutics and Novel Drug Delivery Systems Growth Trends by Region

2.2.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Pharmaceutics and Novel Drug Delivery Systems Historic Market Size by Region (2019-2024)

2.2.3 Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Region (2025-2030)

2.3 Pharmaceutics and Novel Drug Delivery Systems Market Dynamics

2.3.1 Pharmaceutics and Novel Drug Delivery Systems Industry Trends

2.3.2 Pharmaceutics and Novel Drug Delivery Systems Market Drivers

2.3.3 Pharmaceutics and Novel Drug Delivery Systems Market Challenges

2.3.4 Pharmaceutics and Novel Drug Delivery Systems Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Pharmaceutics and Novel Drug Delivery Systems Players by Revenue

3.1.1 Global Top Pharmaceutics and Novel Drug Delivery Systems Players by Revenue (2019-2024)

3.1.2 Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Players (2019-2024)

3.2 Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Pharmaceutics and Novel Drug Delivery Systems Revenue

3.4 Global Pharmaceutics and Novel Drug Delivery Systems Market Concentration Ratio

3.4.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutics and Novel Drug Delivery Systems Revenue in 2023

3.5 Pharmaceutics and Novel Drug Delivery Systems Key Players Head office and Area Served

3.6 Key Players Pharmaceutics and Novel Drug Delivery Systems Product Solution and Service

3.7 Date of Enter into Pharmaceutics and Novel Drug Delivery Systems Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmaceutics and Novel Drug Delivery Systems Breakdown Data by Type

4.1 Global Pharmaceutics and Novel Drug Delivery Systems Historic Market Size by Type (2019-2024)

4.2 Global Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Type (2025-2030)

5 Pharmaceutics and Novel Drug Delivery Systems Breakdown Data by Application

5.1 Global Pharmaceutics and Novel Drug Delivery Systems Historic Market Size by Application (2019-2024)

5.2 Global Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Pharmaceutics and Novel Drug Delivery Systems Market Size (2019-2030)

6.2 North America Pharmaceutics and Novel Drug Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2019-2024)

6.4 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size (2019-2030)

7.2 Europe Pharmaceutics and Novel Drug Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2019-2024)

7.4 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size (2019-2030)

8.2 Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Region (2019-2024)

8.4 Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size (2019-2030)

9.2 Latin America Pharmaceutics and Novel Drug Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2019-2024)

9.4 Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size (2019-2030)

10.2 Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2019-2024)

10.4 Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Amgen

11.1.1 Amgen Company Detail

11.1.2 Amgen Business Overview

11.1.3 Amgen Pharmaceutics and Novel Drug Delivery Systems Introduction

11.1.4 Amgen Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

11.1.5 Amgen Recent Development

11.2 Teva

11.2.1 Teva Company Detail

11.2.2 Teva Business Overview

11.2.3 Teva Pharmaceutics and Novel Drug Delivery Systems Introduction

11.2.4 Teva Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

11.2.5 Teva Recent Development

11.3 Roche

11.3.1 Roche Company Detail

11.3.2 Roche Business Overview

11.3.3 Roche Pharmaceutics and Novel Drug Delivery Systems Introduction

11.3.4 Roche Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

11.3.5 Roche Recent Development

11.4 UCB (Union Chimique Belge)

11.4.1 UCB (Union Chimique Belge) Company Detail

11.4.2 UCB (Union Chimique Belge) Business Overview

11.4.3 UCB (Union Chimique Belge) Pharmaceutics and Novel Drug Delivery Systems Introduction

11.4.4 UCB (Union Chimique Belge) Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

11.4.5 UCB (Union Chimique Belge) Recent Development

11.5 Celgene

11.5.1 Celgene Company Detail

11.5.2 Celgene Business Overview

11.5.3 Celgene Pharmaceutics and Novel Drug Delivery Systems Introduction

11.5.4 Celgene Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

11.5.5 Celgene Recent Development

11.6 Merck

11.6.1 Merck Company Detail

11.6.2 Merck Business Overview

11.6.3 Merck Pharmaceutics and Novel Drug Delivery Systems Introduction

11.6.4 Merck Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

11.6.5 Merck Recent Development

11.7 Gilead Sciences

11.7.1 Gilead Sciences Company Detail

11.7.2 Gilead Sciences Business Overview

11.7.3 Gilead Sciences Pharmaceutics and Novel Drug Delivery Systems Introduction

11.7.4 Gilead Sciences Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

11.7.5 Gilead Sciences Recent Development

11.8 Sanofi

11.8.1 Sanofi Company Detail

11.8.2 Sanofi Business Overview

11.8.3 Sanofi Pharmaceutics and Novel Drug Delivery Systems Introduction

11.8.4 Sanofi Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

11.8.5 Sanofi Recent Development

11.9 Pfizer

11.9.1 Pfizer Company Detail

11.9.2 Pfizer Business Overview

11.9.3 Pfizer Pharmaceutics and Novel Drug Delivery Systems Introduction

11.9.4 Pfizer Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

11.9.5 Pfizer Recent Development

11.10 Takeda

11.10.1 Takeda Company Detail

11.10.2 Takeda Business Overview

11.10.3 Takeda Pharmaceutics and Novel Drug Delivery Systems Introduction

11.10.4 Takeda Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

11.10.5 Takeda Recent Development

11.11 Bausch&Lomb

11.11.1 Bausch&Lomb Company Detail

11.11.2 Bausch&Lomb Business Overview

11.11.3 Bausch&Lomb Pharmaceutics and Novel Drug Delivery Systems Introduction

11.11.4 Bausch&Lomb Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

11.11.5 Bausch&Lomb Recent Development

11.12 Samyang Biopharmaceuticals

11.12.1 Samyang Biopharmaceuticals Company Detail

11.12.2 Samyang Biopharmaceuticals Business Overview

11.12.3 Samyang Biopharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Introduction

11.12.4 Samyang Biopharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

11.12.5 Samyang Biopharmaceuticals Recent Development

11.13 Johnson & Johnson

11.13.1 Johnson & Johnson Company Detail

11.13.2 Johnson & Johnson Business Overview

11.13.3 Johnson & Johnson Pharmaceutics and Novel Drug Delivery Systems Introduction

11.13.4 Johnson & Johnson Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

11.13.5 Johnson & Johnson Recent Development

11.14 TOLMAR

11.14.1 TOLMAR Company Detail

11.14.2 TOLMAR Business Overview

11.14.3 TOLMAR Pharmaceutics and Novel Drug Delivery Systems Introduction

11.14.4 TOLMAR Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

11.14.5 TOLMAR Recent Development

11.15 Astellas

11.15.1 Astellas Company Detail

11.15.2 Astellas Business Overview

11.15.3 Astellas Pharmaceutics and Novel Drug Delivery Systems Introduction

11.15.4 Astellas Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

11.15.5 Astellas Recent Development

11.16 AMAG Pharmaceuticals

11.16.1 AMAG Pharmaceuticals Company Detail

11.16.2 AMAG Pharmaceuticals Business Overview

11.16.3 AMAG Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Introduction

11.16.4 AMAG Pharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

11.16.5 AMAG Pharmaceuticals Recent Development

11.17 AbbVie

11.17.1 AbbVie Company Detail

11.17.2 AbbVie Business Overview

11.17.3 AbbVie Pharmaceutics and Novel Drug Delivery Systems Introduction

11.17.4 AbbVie Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

11.17.5 AbbVie Recent Development

11.18 Dr Reddy

11.18.1 Dr Reddy Company Detail

11.18.2 Dr Reddy Business Overview

11.18.3 Dr Reddy Pharmaceutics and Novel Drug Delivery Systems Introduction

11.18.4 Dr Reddy Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

11.18.5 Dr Reddy Recent Development

11.19 AstraZeneca

11.19.1 AstraZeneca Company Detail

11.19.2 AstraZeneca Business Overview

11.19.3 AstraZeneca Pharmaceutics and Novel Drug Delivery Systems Introduction

11.19.4 AstraZeneca Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

11.19.5 AstraZeneca Recent Development

11.20 Aspen

11.20.1 Aspen Company Detail

11.20.2 Aspen Business Overview

11.20.3 Aspen Pharmaceutics and Novel Drug Delivery Systems Introduction

11.20.4 Aspen Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

11.20.5 Aspen Recent Development

11.21 Acrotech Biopharma

11.21.1 Acrotech Biopharma Company Detail

11.21.2 Acrotech Biopharma Business Overview

11.21.3 Acrotech Biopharma Pharmaceutics and Novel Drug Delivery Systems Introduction

11.21.4 Acrotech Biopharma Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

11.21.5 Acrotech Biopharma Recent Development

11.22 TWi Pharmaceuticals

11.22.1 TWi Pharmaceuticals Company Detail

11.22.2 TWi Pharmaceuticals Business Overview

11.22.3 TWi Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Introduction

11.22.4 TWi Pharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

11.22.5 TWi Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

Table 1. Global Pharmaceutics and Novel Drug Delivery Systems Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Liposomes

Table 3. Key Players of PEGylated Proteins & Polypeptides

Table 4. Key Players of Polymer Nanoparticle

Table 5. Key Players of Protein–drug Conjugates

Table 6. Key Players of Other

Table 7. Global Pharmaceutics and Novel Drug Delivery Systems Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Pharmaceutics and Novel Drug Delivery Systems Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Pharmaceutics and Novel Drug Delivery Systems Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Region (2019-2024)

Table 11. Global Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Region (2025-2030)

Table 13. Pharmaceutics and Novel Drug Delivery Systems Market Trends

Table 14. Pharmaceutics and Novel Drug Delivery Systems Market Drivers

Table 15. Pharmaceutics and Novel Drug Delivery Systems Market Challenges

Table 16. Pharmaceutics and Novel Drug Delivery Systems Market Restraints

Table 17. Global Pharmaceutics and Novel Drug Delivery Systems Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Players (2019-2024)

Table 19. Global Top Pharmaceutics and Novel Drug Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutics and Novel Drug Delivery Systems as of 2023)

Table 20. Ranking of Global Top Pharmaceutics and Novel Drug Delivery Systems Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Pharmaceutics and Novel Drug Delivery Systems Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Pharmaceutics and Novel Drug Delivery Systems Product Solution and Service

Table 24. Date of Enter into Pharmaceutics and Novel Drug Delivery Systems Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Type (2019-2024)

Table 28. Global Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Type (2025-2030)

Table 30. Global Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Application (2019-2024)

Table 32. Global Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Application (2025-2030)

Table 34. North America Pharmaceutics and Novel Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Pharmaceutics and Novel Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2025-2030) & (US$ Million)

Table 49. Amgen Company Detail

Table 50. Amgen Business Overview

Table 51. Amgen Pharmaceutics and Novel Drug Delivery Systems Product

Table 52. Amgen Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 53. Amgen Recent Development

Table 54. Teva Company Detail

Table 55. Teva Business Overview

Table 56. Teva Pharmaceutics and Novel Drug Delivery Systems Product

Table 57. Teva Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 58. Teva Recent Development

Table 59. Roche Company Detail

Table 60. Roche Business Overview

Table 61. Roche Pharmaceutics and Novel Drug Delivery Systems Product

Table 62. Roche Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 63. Roche Recent Development

Table 64. UCB (Union Chimique Belge) Company Detail

Table 65. UCB (Union Chimique Belge) Business Overview

Table 66. UCB (Union Chimique Belge) Pharmaceutics and Novel Drug Delivery Systems Product

Table 67. UCB (Union Chimique Belge) Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 68. UCB (Union Chimique Belge) Recent Development

Table 69. Celgene Company Detail

Table 70. Celgene Business Overview

Table 71. Celgene Pharmaceutics and Novel Drug Delivery Systems Product

Table 72. Celgene Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 73. Celgene Recent Development

Table 74. Merck Company Detail

Table 75. Merck Business Overview

Table 76. Merck Pharmaceutics and Novel Drug Delivery Systems Product

Table 77. Merck Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 78. Merck Recent Development

Table 79. Gilead Sciences Company Detail

Table 80. Gilead Sciences Business Overview

Table 81. Gilead Sciences Pharmaceutics and Novel Drug Delivery Systems Product

Table 82. Gilead Sciences Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 83. Gilead Sciences Recent Development

Table 84. Sanofi Company Detail

Table 85. Sanofi Business Overview

Table 86. Sanofi Pharmaceutics and Novel Drug Delivery Systems Product

Table 87. Sanofi Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 88. Sanofi Recent Development

Table 89. Pfizer Company Detail

Table 90. Pfizer Business Overview

Table 91. Pfizer Pharmaceutics and Novel Drug Delivery Systems Product

Table 92. Pfizer Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 93. Pfizer Recent Development

Table 94. Takeda Company Detail

Table 95. Takeda Business Overview

Table 96. Takeda Pharmaceutics and Novel Drug Delivery Systems Product

Table 97. Takeda Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 98. Takeda Recent Development

Table 99. Bausch&Lomb Company Detail

Table 100. Bausch&Lomb Business Overview

Table 101. Bausch&Lomb Pharmaceutics and Novel Drug Delivery Systems Product

Table 102. Bausch&Lomb Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 103. Bausch&Lomb Recent Development

Table 104. Samyang Biopharmaceuticals Company Detail

Table 105. Samyang Biopharmaceuticals Business Overview

Table 106. Samyang Biopharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Product

Table 107. Samyang Biopharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 108. Samyang Biopharmaceuticals Recent Development

Table 109. Johnson & Johnson Company Detail

Table 110. Johnson & Johnson Business Overview

Table 111. Johnson & Johnson Pharmaceutics and Novel Drug Delivery Systems Product

Table 112. Johnson & Johnson Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 113. Johnson & Johnson Recent Development

Table 114. TOLMAR Company Detail

Table 115. TOLMAR Business Overview

Table 116. TOLMAR Pharmaceutics and Novel Drug Delivery Systems Product

Table 117. TOLMAR Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 118. TOLMAR Recent Development

Table 119. Astellas Company Detail

Table 120. Astellas Business Overview

Table 121. Astellas Pharmaceutics and Novel Drug Delivery Systems Product

Table 122. Astellas Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 123. Astellas Recent Development

Table 124. AMAG Pharmaceuticals Company Detail

Table 125. AMAG Pharmaceuticals Business Overview

Table 126. AMAG Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Product

Table 127. AMAG Pharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 128. AMAG Pharmaceuticals Recent Development

Table 129. AbbVie Company Detail

Table 130. AbbVie Business Overview

Table 131. AbbVie Pharmaceutics and Novel Drug Delivery Systems Product

Table 132. AbbVie Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 133. AbbVie Recent Development

Table 134. Dr Reddy Company Detail

Table 135. Dr Reddy Business Overview

Table 136. Dr Reddy Pharmaceutics and Novel Drug Delivery Systems Product

Table 137. Dr Reddy Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 138. Dr Reddy Recent Development

Table 139. AstraZeneca Company Detail

Table 140. AstraZeneca Business Overview

Table 141. AstraZeneca Pharmaceutics and Novel Drug Delivery Systems Product

Table 142. AstraZeneca Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 143. AstraZeneca Recent Development

Table 144. Aspen Company Detail

Table 145. Aspen Business Overview

Table 146. Aspen Pharmaceutics and Novel Drug Delivery Systems Product

Table 147. Aspen Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 148. Aspen Recent Development

Table 149. Acrotech Biopharma Company Detail

Table 150. Acrotech Biopharma Business Overview

Table 151. Acrotech Biopharma Pharmaceutics and Novel Drug Delivery Systems Product

Table 152. Acrotech Biopharma Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 153. Acrotech Biopharma Recent Development

Table 154. TWi Pharmaceuticals Company Detail

Table 155. TWi Pharmaceuticals Business Overview

Table 156. TWi Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Product

Table 157. TWi Pharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)

Table 158. TWi Pharmaceuticals Recent Development

Table 159. Research Programs/Design for This Report

Table 160. Key Data Information from Secondary Sources

Table 161. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Pharmaceutics and Novel Drug Delivery Systems Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Type: 2023 VS 2030

Figure 3. Liposomes Features

Figure 4. PEGylated Proteins & Polypeptides Features

Figure 5. Polymer Nanoparticle Features

Figure 6. Protein–drug Conjugates Features

Figure 7. Other Features

Figure 8. Global Pharmaceutics and Novel Drug Delivery Systems Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Application: 2023 VS 2030

Figure 10. Hospitals & Clinic Case Studies

Figure 11. Cancer Treatment Centers Case Studies

Figure 12. Others Case Studies

Figure 13. Pharmaceutics and Novel Drug Delivery Systems Report Years Considered

Figure 14. Global Pharmaceutics and Novel Drug Delivery Systems Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Pharmaceutics and Novel Drug Delivery Systems Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Region: 2023 VS 2030

Figure 17. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Players in 2023

Figure 18. Global Top Pharmaceutics and Novel Drug Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutics and Novel Drug Delivery Systems as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Pharmaceutics and Novel Drug Delivery Systems Revenue in 2023

Figure 20. North America Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Pharmaceutics and Novel Drug Delivery Systems Market Share by Country (2019-2030)

Figure 22. United States Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Pharmaceutics and Novel Drug Delivery Systems Market Share by Country (2019-2030)

Figure 26. Germany Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Share by Region (2019-2030)

Figure 34. China Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Pharmaceutics and Novel Drug Delivery Systems Market Share by Country (2019-2030)

Figure 42. Mexico Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Share by Country (2019-2030)

Figure 46. Turkey Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Amgen Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

Figure 49. Teva Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

Figure 50. Roche Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

Figure 51. UCB (Union Chimique Belge) Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

Figure 52. Celgene Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

Figure 53. Merck Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

Figure 54. Gilead Sciences Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

Figure 55. Sanofi Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

Figure 56. Pfizer Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

Figure 57. Takeda Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

Figure 58. Bausch&Lomb Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

Figure 59. Samyang Biopharmaceuticals Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

Figure 60. Johnson & Johnson Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

Figure 61. TOLMAR Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

Figure 62. Astellas Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

Figure 63. AMAG Pharmaceuticals Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

Figure 64. AbbVie Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

Figure 65. Dr Reddy Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

Figure 66. AstraZeneca Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

Figure 67. Aspen Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

Figure 68. Acrotech Biopharma Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

Figure 69. TWi Pharmaceuticals Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Stainless Steel Medication Trolley Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-18N15820

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Instant Molecular Testing Service Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-33G15638

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Universal Cell Therapy Drug Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-14U15769

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Preclinical Toxicology Testing Service Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-1P15930

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Pharmaceutics and Novel Drug Delivery Systems Market Research Report 2024

Published Date: May 2024

Report Code: QYRE-Auto-13W9949

Global Pharmaceutics and Novel Drug Delivery Systems Market Research Report 2024

FEATURED COMPANIES

Pharmaceutics and Novel Drug Delivery Systems Market Size

Pharmaceutics and Novel Drug Delivery Systems Market

Report Scope

Scope of Pharmaceutics and Novel Drug Delivery Systems Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Pharmaceutics and Novel Drug Delivery Systems Market report?

What are the Application segmentation covered in the Pharmaceutics and Novel Drug Delivery Systems Market report?

What are the Type segmentation covered in the Pharmaceutics and Novel Drug Delivery Systems Market report?

FEATURED COMPANIES

RELATED REPORTS